Floatz logo

4sc-201

Advanced Colorectal Carcinoma

4SC AGPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
81/ 100

Competitive context

161 Active assets in the Advanced Colorectal Carcinoma cohort.

Asset / SponsorPhaseRating
TIPIRACIL
Mayo Clinic
Phase 2BBB
FLUOROURACILUM
City of Hope Medical Center
Phase 4BB
Eloxatin
First Affiliated Hospital of Zhejiang University
Phase 4BB
MITOMYCIN C
City of Hope Medical Center
Phase 3BB
Capecitabine
First Affiliated Hospital of Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

4sc-201 is also rated in:

mycosis fungoidesDormant
B
Indicative ·
61 / 100
View asset →
Sezary syndromeDormant
B
Indicative ·
61 / 100
View asset →
primary cutaneous T-cell non-Hodgkin lymphomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →